UPDATE 3-Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17.5 bln deal

Ginkgo said on Tuesday it was planning to go public through a merger with a blank-check vehicle backed by former Hollywood executives Harry Sloan and Jeff Sagansky, in one of the biggest such deals that values the biotech company at $17.5 billion.